Survodutide Clinic Near Rochester: 2026 Weight and Liver Guide
If you have been searching for a survodutide clinic near Rochester, you have probably seen the headlines from this year’s American Diabetes Association meeting, where Boehringer Ingelheim presented phase 3 results for its investigational weight loss medication. Survodutide is drawing attention for a reason that goes beyond the scale: it appears to target visceral fat and liver fat in a way that could matter enormously for the many people in Monroe County living with obesity-related metabolic and fatty liver disease.
At Vital Health Medical Care in Pittsford, New York, located at 10 Office Parkway, Suite 100, directly across from the Jefferson and Clover Road YMCA, Dr. Sanin Syed tracks emerging obesity medications like survodutide so her patients in Rochester, Brighton, Penfield, Fairport, Victor, Webster, and Henrietta can separate real science from marketing. Dr. Syed is dual board-certified by the American Board of Obesity Medicine and the American Board of Internal Medicine, is an Assistant Professor of Medicine at the University of Rochester Medical Center, and has more than 20 years of experience in medicine and obesity medicine. This guide explains what survodutide is, what the latest research shows, when it might become available, and what you can do right now.
Quick Answer: Is Survodutide Available in Rochester, NY?
Not yet. Survodutide is an investigational medication that has not been approved by the U.S. Food and Drug Administration (FDA), and Boehringer Ingelheim states that its efficacy and safety have not been established for general use. It cannot legally be prescribed at any clinic in Rochester, New York, or anywhere else in the United States outside of a registered clinical trial.
What Rochester patients can access today are FDA-approved medications with years of evidence behind them, including Wegovy (semaglutide) and Zepbound (tirzepatide), offered through physician-supervised programs such as the one at Vital Health Medical Care. Wegovy has also received FDA approval for adults with metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis, which is especially relevant for patients who are interested in survodutide because of its liver effects.
[Internal link opportunity: FDA-Approved Weight Loss Medicines in Rochester, NY page]What Is Survodutide?
A Glucagon and GLP-1 Dual Agonist
Survodutide, also known by its development code BI 456906, is a once-weekly injectable peptide developed by Boehringer Ingelheim under license from Zealand Pharma. It activates two receptors at the same time: the glucagon-like peptide-1 (GLP-1) receptor and the glucagon receptor. Its design is based on oxyntomodulin, a natural gut hormone that acts on both pathways.
How the Two Pathways Work Together
The GLP-1 component works much like semaglutide, reducing appetite, increasing fullness after meals, and slowing digestion. The glucagon component is what makes survodutide different. Glucagon receptors are highly concentrated in the liver, and activating them is thought to increase energy expenditure and help the liver burn stored fat. Researchers believe this combination may be particularly effective at reducing visceral fat and liver fat, the types of fat most strongly linked to type 2 diabetes, heart disease, and fatty liver disease.
How It Differs From Semaglutide, Tirzepatide, and Retatrutide
Semaglutide targets GLP-1 alone, and tirzepatide targets GLP-1 plus GIP. Retatrutide, another investigational drug many Rochester patients ask about, targets GLP-1, GIP, and glucagon. Survodutide sits in its own category by pairing GLP-1 with glucagon without GIP, which is why much of its research focuses on metabolic liver disease in addition to weight loss.
[Internal link opportunity: Retatrutide Clinic Near Rochester NY page]What the Latest Survodutide Research Shows
SYNCHRONIZE-1: Phase 3 Weight Loss Results
In the phase 3 SYNCHRONIZE-1 trial, published in The New England Journal of Medicine in June 2026, 725 adults with obesity or overweight but without type 2 diabetes received weekly survodutide or placebo for 76 weeks. According to Boehringer Ingelheim, participants on the higher dose lost up to an average of 16.6% of body weight, compared with 3.2% on placebo, in an analysis that assumed participants stayed on treatment for the full study. Real-world results tend to vary, since not every person tolerates or continues a medication for the entire course.
Visceral Fat, Liver Fat, and Lean Muscle
A pre-specified MRI sub-study of SYNCHRONIZE-1 reported that survodutide reduced visceral fat by up to 34% and liver fat by up to 63.1% relative to baseline, according to results presented by Boehringer Ingelheim at ADA 2026. The same analysis found that lean mass accounted for no more than about 11.3% of the total tissue lost at the highest dose, suggesting that most of the weight lost was fat rather than muscle, although these findings come from a subgroup of participants and will need confirmation in broader populations.
SYNCHRONIZE-MASLD: Results in Fatty Liver Disease
The SYNCHRONIZE-MASLD trial, published in Nature Medicine, studied 218 adults with obesity or overweight and metabolic dysfunction-associated steatotic liver disease (MASLD) with signs of inflammation or fibrosis. Boehringer Ingelheim reported that after 48 weeks, up to 84.2% of participants on survodutide achieved at least a 30% relative reduction in liver fat, compared with 24.3% on placebo, and about 61% reached normal liver fat levels, compared with roughly 5.7% on placebo. Average body weight fell by up to 12.2% in the same trial, versus about 1% on placebo.
Why the Liver Findings Matter
Boehringer Ingelheim notes, citing published research, that up to three in four people living with obesity may have MASLD, and a portion of them progress to MASH, a more serious form involving inflammation and liver damage. Because fatty liver disease often causes no symptoms until it is advanced, many people in the Rochester area may not know they have it. The FDA has granted survodutide Breakthrough Therapy designation for MASH with moderate or advanced fibrosis, and the large phase 3 LIVERAGE trials are now studying whether it can improve liver scarring over time.
Survodutide Side Effects and Safety Considerations
In SYNCHRONIZE-1, the most common side effects were gastrointestinal, including nausea, vomiting, diarrhea, and constipation, and most were reported as mild to moderate and occurring during the dose-escalation phase. Notably, Boehringer Ingelheim reported that about 19% of participants on survodutide stopped treatment because of gastrointestinal side effects, compared with about 2.9% on placebo, which is higher than many patients might expect. The company has said it is studying slower, more patient-centered titration approaches in a new trial called SYNCHRONIZE-START.
No new safety signals were identified in the published phase 3 trials, but long-term data, including results from the ongoing SYNCHRONIZE-CVOT cardiovascular safety trial, are still pending. Anyone with a history of pancreatitis, gallbladder disease, certain thyroid cancers, significant gastrointestinal disorders, or who is pregnant or planning pregnancy should review these factors carefully with a physician before starting any incretin-based therapy, approved or investigational.
When Could Survodutide Be Available?
There is no confirmed approval date. SYNCHRONIZE-2, which studies survodutide in adults with obesity and type 2 diabetes, was expected by industry observers to report results later in 2026, and the cardiovascular outcomes and MASH trials are still underway. The timing of any FDA submission and review is uncertain, so it is reasonable to expect that survodutide may not reach Rochester pharmacies for some time, and estimates like these can shift as trial results arrive.
For most patients, waiting is not the healthiest strategy. Starting a proven program now can begin to improve blood pressure, blood sugar, liver enzymes, sleep, and joint pain, and it establishes a relationship with an obesity medicine specialist who can evaluate new options as they are approved.
Beware of “Survodutide” Sold Online
Some websites now sell products labeled as survodutide or “research peptides,” often with fine print stating they are not for human use. These products are not FDA-approved, are not produced under pharmaceutical manufacturing standards, and may contain the wrong dose, contaminants, or an entirely different substance. Injecting an unverified product without medical supervision carries serious risks, including infection, dosing errors, and unmonitored side effects. If you have seen such an offer, the safest step is to speak with a board-certified obesity medicine physician about legitimate options, including approved medications and registered clinical trials listed on ClinicalTrials.gov.
[Internal link opportunity: Medical Peptide Therapy for Weight Loss in Rochester, NY page]How Survodutide Compares With Options Available Today
The table below summarizes the key differences between survodutide and the FDA-approved medications Rochester patients can use now.
| Feature | Survodutide | Semaglutide (Wegovy) | Tirzepatide (Zepbound) |
| Hormone targets | GLP-1 + glucagon | GLP-1 | GLP-1 + GIP |
| FDA status (Sept 2026) | Investigational, in phase 3 trials | FDA-approved | FDA-approved |
| Dosing | Weekly injection | Weekly injection; daily pill | Weekly injection |
| Liver disease focus | Studied in MASLD and MASH; Breakthrough Therapy designation for MASH | FDA-approved for MASH with moderate to advanced fibrosis | Studied in MASH |
| Available in Rochester now? | No, clinical trials only | Yes, by prescription | Yes, by prescription |
| Common side effects | Gastrointestinal | Gastrointestinal | Gastrointestinal |
Comparing percentages across different trials can be misleading, because study populations, durations, and analysis methods differ. The best medication for you depends on your medical history, liver health, goals, tolerance of side effects, and insurance coverage.
What to Look For in a Survodutide Clinic Near Rochester
When survodutide or any new obesity medication eventually becomes available, the clinic you choose will matter as much as the drug itself. Look for a practice that offers the following:
- A physician board-certified in obesity medicine who follows the primary research and can explain whether a new drug is right for you.
- Prescribing of FDA-approved, brand-name medications rather than unregulated compounded or “research” products.
- Body composition analysis to confirm that weight loss comes from fat, including visceral fat, rather than muscle.
- Attention to metabolic and liver health, including labs and appropriate referral when advanced liver disease is suspected.
- Nutrition, exercise, and behavioral support, since medication works best as part of a comprehensive plan.
- Help with insurance verification and prior authorization.
Vital Health Medical Care in Pittsford was built around exactly these principles.
Proven Weight Loss Care at Vital Health Medical Care Today
Semaglutide (Wegovy, and Ozempic for Type 2 Diabetes)
Semaglutide is a once-weekly GLP-1 receptor agonist that reduces appetite and improves blood sugar control. In the STEP 1 clinical trial, adults taking semaglutide 2.4 mg lost an average of roughly 15% of body weight over 68 weeks, with individual results varying. Wegovy is FDA-approved for chronic weight management, cardiovascular risk reduction in eligible adults, and MASH with moderate to advanced fibrosis, while Ozempic is approved for type 2 diabetes, so Dr. Syed selects the right formulation for each patient’s diagnosis and coverage.
[Internal link opportunity: Semaglutide Clinic Rochester NY page]Zepbound (Tirzepatide)
Zepbound activates both GLP-1 and GIP receptors. In the SURMOUNT-1 clinical trial, adults on the highest dose lost roughly 20% of body weight on average over 72 weeks, although results differ from person to person. It remains one of the most effective non-surgical weight loss treatments available.
[Internal link opportunity: Best Weight Loss Injections in Rochester, NY page]Body Composition Analysis That Tracks Visceral Fat
Because survodutide’s most exciting results involve visceral fat and lean muscle, it is worth noting that Vital Health Medical Care already measures these factors today. The clinic’s medical-grade body composition analysis assesses body fat percentage, visceral and subcutaneous fat, lean muscle mass, hydration, and basal metabolic rate. Monthly scans help Dr. Syed adjust medication, protein intake, and exercise so patients lose fat while protecting muscle.
Nutrition, Culinary Medicine, Exercise, and Behavioral Coaching
Registered dietitians design personalized meal plans, and Dr. Syed’s training in lifestyle, plant-based, and culinary medicine helps patients learn to cook satisfying, nutrient-dense meals, whether they are shopping at Wegmans on the way home or planning dinners for a busy family. Meal replacements, individualized exercise plans that work through long Rochester winters, behavioral coaching for emotional eating and stress, and ongoing health coaching round out a complete program.
Why Rochester Patients Trust Dr. Sanin Syed
Dr. Syed’s expertise has been featured on NPR’s Evan Dawson show and at the Rochester Academy of Medicine, and she received the Best Teacher Award from the Internal Medicine residents of the University of Rochester. She is an active member of the American Society of Obesity Medicine and continues advanced training, including a weeklong obesity medicine CME conference in Colorado. As an internal medicine physician, she evaluates weight in the context of your whole health, including blood pressure, cholesterol, blood sugar, and liver function.
Care follows a clear four-step process: a comprehensive consultation, a baseline body composition scan, a customized treatment plan, and ongoing monitoring with regular adjustments. Vital Health Medical Care works with a wide range of insurance plans, and its team helps patients verify benefits before starting, since coverage for weight loss medications varies by plan. No referral is required.
[Internal link opportunity: About Dr. Sanin Syed page]Practical Steps to Take While You Wait for Survodutide
- Schedule an evaluation with a board-certified obesity medicine physician to review your weight history, labs, and metabolic risks.
- Ask about your liver health, since fatty liver disease is common with obesity and often has no symptoms.
- Discuss whether an FDA-approved medication such as Wegovy or Zepbound makes sense for you now.
- Get a baseline body composition scan to measure visceral fat and lean muscle.
- Prioritize adequate protein and regular resistance training to help preserve muscle during weight loss.
- Avoid online products marketed as survodutide, and if you are interested in research, search ClinicalTrials.gov and review eligibility with your physician.
Frequently Asked Questions About Survodutide in Rochester, NY
What is survodutide?
Survodutide is an investigational once-weekly injectable medication developed by Boehringer Ingelheim for obesity and metabolic liver disease. It activates both GLP-1 and glucagon receptors, which work together to reduce appetite and help the liver burn stored fat.
Is there a survodutide clinic near Rochester that can prescribe it now?
No clinic in Rochester, New York, can prescribe survodutide at this time because it is not FDA-approved. Vital Health Medical Care in Pittsford offers FDA-approved alternatives, including Wegovy and Zepbound, and Dr. Sanin Syed can discuss survodutide with patients as new information becomes available.
How much weight did people lose on survodutide?
In the phase 3 SYNCHRONIZE-1 trial, adults without diabetes on the higher dose lost up to an average of 16.6% of body weight over 76 weeks, compared with 3.2% on placebo, according to Boehringer Ingelheim. Individual results varied, and that figure assumed participants stayed on treatment for the full trial.
Does survodutide help with fatty liver disease?
Early evidence suggests it may. In the SYNCHRONIZE-MASLD trial, about 61% of participants on survodutide reached normal liver fat levels after 48 weeks, compared with roughly 5.7% on placebo. Larger trials are now studying whether it can improve liver scarring in people with MASH.
How is survodutide different from Wegovy and Zepbound?
Wegovy targets GLP-1 alone, and Zepbound targets GLP-1 and GIP. Survodutide combines GLP-1 with glucagon, which acts strongly in the liver. Wegovy and Zepbound are FDA-approved and available now, while survodutide is still investigational.
What are the side effects of survodutide?
The most common side effects in clinical trials were nausea, vomiting, diarrhea, and constipation, mostly mild to moderate and most frequent while the dose was being increased. About 19% of trial participants stopped the medication because of gastrointestinal side effects, according to the company’s phase 3 data.
When will survodutide be approved?
No approval date has been announced. Additional phase 3 results, including trials in people with type 2 diabetes and cardiovascular disease, are still being completed, so any approval timeline remains uncertain.
Does insurance cover weight loss medications in Rochester?
Coverage depends on your plan. Many commercial insurance plans cover FDA-approved medications like Wegovy or Zepbound for eligible patients, often with prior authorization. Survodutide is not covered because it is not approved. Vital Health Medical Care helps new patients verify their benefits before starting treatment.
How do I schedule an appointment with Dr. Syed?
Call Vital Health Medical Care at 585-662-5786 or visit www.vitalhealthmedicalcare.com. No referral is needed, and the clinic is located at 10 Office Parkway, Suite 100, Pittsford, NY.
Start Your Weight Loss Journey in Rochester Today
Survodutide is one of the most promising medications in the obesity pipeline, especially for people concerned about visceral fat and fatty liver disease. Still, anyone looking for a survodutide clinic near Rochester deserves an honest answer: the drug remains in clinical trials, and the most effective step you can take today is to begin a comprehensive, physician-supervised program using proven, FDA-approved treatments.
At Vital Health Medical Care, Dr. Sanin Syed brings dual board-certified expertise, advanced body composition analysis, FDA-approved medications such as Wegovy and Zepbound, personalized nutrition, and behavioral support together under one roof in Pittsford. When new treatments like survodutide are approved, her patients will already have an expert on their side who can explain the evidence and help decide whether it fits their goals.
Meet Dr. Sanin Syed – Leading Medical Weight Loss Specialist in Rochester, NY
Dr. Sanin Syed, founder and CEO of Vital Health Medical Care, is a board-certified obesity and internal medicine specialist. With over two decades of experience, Dr. Syed is dedicated to helping her patients achieve lasting weight loss and a healthier lifestyle.
- Recognized Expertise: Dr. Syed’s knowledge has been featured on NPR’s Evan Dawson Show and in the Rochester Academy of Medicine.
- Commitment to Patient Health: She focuses on building sustainable health habits and lifestyle changes that support long-term success.
Our clinic, located at 10 Office Parkway, Suite 100, Pittsford, NY, provides a welcoming and professional setting for patients who are ready to make positive changes.
Why Choose Vital Health Medical Care?
Experienced Weight Loss Doctor
Dr. Sanin Syed is one of the leading weight loss doctors in New York, with over 20 years of experience in medicine and obesity management. She holds dual board certifications from the American Board of Obesity Medicine and the American Board of Internal Medicine, ensuring you receive the highest standard of care.
Personalized Care
At Vital Health Medical Care, we believe in a personalized approach to weight loss. Our programs are tailored to meet your unique needs, ensuring you receive the best possible care and support on your weight loss journey.
Comprehensive Support
We provide ongoing support throughout your weight loss journey, including regular monitoring and adjustments to your plan as needed. Our comprehensive approach ensures you have the resources and guidance necessary to achieve your weight loss goals.
Insurance Acceptance
We understand that managing healthcare costs is important. That’s why we accept a wide range of insurance plans to make our weight loss treatments accessible and affordable for everyone.
Nutritional Counseling
Our qualified nutritionists create personalized diet plans that fit your lifestyle and dietary preferences. We provide expert guidance on making healthy food choices that support your weight loss goals.
Physician Consultation
Our experienced physicians, led by Dr. Syed, will work with you to find the best medication and treatment plan for your needs. We utilize FDA-approved medications such as Wegovy and Zepbound to support your weight loss efforts.
Health Coaching
Our health coaches provide ongoing support and motivation, helping you stay on track with your weight loss goals. They offer practical advice and encouragement to help you overcome challenges and achieve lasting success.
Culinary Medicine
Learn how to prepare healthy, delicious meals that support your weight loss journey with guidance from our culinary medicine experts. We offer cooking classes and workshops to help you develop the skills needed to maintain a healthy diet.
Meal Replacement
We offer meal replacement options that are nutritious and convenient, helping you manage your calorie intake effectively. Our meal replacements are designed to support your weight loss goals while ensuring you receive essential nutrients.
Individualized Exercise Plan
Our fitness experts develop personalized exercise plans tailored to your fitness level and goals. We provide guidance on the best types of exercise for weight loss and overall health, ensuring you achieve optimal results.
Comprehensive Weight Loss Treatment in Rochester, New York
Vital Health Medical Care offers evidence-based weight loss treatments designed to help you succeed. We take a holistic approach, integrating medication, diet, exercise, and behavioral changes to ensure long-term success. Contact us today to schedule a consultation and start your journey.